Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | AZD5069 |
| Trade Name | |
| Synonyms | AZD-5069|AZD 5069 |
| Drug Descriptions |
AZD5069 binds to and inhibits CXCR2 signaling, resulting in reduced neutrophil chemotaxis (PMID: 25736418, PMID: 29856004). |
| DrugClasses | CXCR Antagonist 4 |
| CAS Registry Number | 878385-84-3 |
| NCIT ID | C123383 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| AZD5069 | AZD5069 | 0 | 0 |
| AZD5069 + Durvalumab | AZD5069 Durvalumab | 0 | 2 |
| AZD5069 + Enzalutamide | AZD5069 Enzalutamide | 0 | 1 |